Laura Sepp-Lorenzino
| Use attributes for filter ! | |
| Interests | Genome Editing |
|---|---|
| Delivery | |
| Nucleic Acid Therapies | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 3571629 |
About Laura Sepp-Lorenzino
Laura Sepp-Lorenzino is Executive Vice President, Chief Scientific Officer at Intellia Therapeutics, a company developing curative genome editing treatments to positively transform the lives of people with genetic diseases. She oversees all drug research across in vivo and engineered cell therapy areas at Intellia.
